In another study, it was observed that activation of FXR by GW4064 led to the upregulation of death receptor 5 (DR5), and reduced cell proliferation upon treatment with TRAIL and GW4064 in CRC cell lines (HCT-116, SW480, DLD-1) [170]. This evidence concerns the gene TNFRSF10B and colorectal carcinoma.